Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO_NAT
2023-504188-18-00Phase 4Authorised
- Sponsor
- Instituto Bernabeu
- Start
- May 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in female infertility comparing Seidigestan protocol with Astarté protocol (2 arms). Primary endpoint: Number of oocytes obtained at metaphase II (MII) stage. Planned start May 2023; status: authorised.
02
Drugs
progesteroneganirelix
03
Conditions
female infertility
Beyond the preview
Go deeper on 2023-504188-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504188-18-00.